US 9567566
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
granted A61KA61K2039/53A61K2039/55516
Quick answer
US patent 9567566 (HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/53, A61K2039/55516, A61K2039/57, A61K38/1709